Press release
Investigation for Investors in Athenex, Inc. (NASDAQ: ATNX) over possible Violations of Securities Laws announced
An investigation for investors in Athenex, Inc. (NASDAQ: ATNX) shares over potential securities laws violations by Athenex, Inc.
Investors who purchased shares of Athenex, Inc. (NASDAQ: ATNX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Athenex, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Buffalo, NY based Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North America and Asia.
In June 2017, Athenex, Inc. completed its initial public offering ("IPO"), issuing 6 million shares of common stock priced at $11.00 per share.
Athenex, Inc. reported that its annual Total Revenue rose from $89.1 million in 2018 to $101.22 million in 2019, and that its Net Loss increased from $117.44 million in 2018 to $123.74 million in 2019.
Then, on May 7, 2020, Athenex reported its financial and operating results for the first quarter of 2020. Among other results, the Company reported earnings per share that missed consensus estimates by $0.07.
Shares of Athenex, Inc. (NASDAQ: ATNX) declined on March 18, 2020, to as low as $5.63 per share.
Those who purchased shares of Athenex, Inc. (NASDAQ: ATNX) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation for Investors in Athenex, Inc. (NASDAQ: ATNX) over possible Violations of Securities Laws announced here
News-ID: 2064227 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for certain Investors who lost money with shares of Global Cord Bl …
An investor, who purchased shares of Global Cord Blood Corporation (OTC: CORBF), filed a lawsuit over alleged violations of Federal Securities Laws by Global Cord Blood Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Global Cord Blood Corporation (OTC: CORBF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. OTC: CORBF investors should contact the Shareholders…
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ …
An investor, who purchased shares of Autodesk, Inc. (NASDAQ: ADSK), filed a lawsuit over alleged violations of Federal Securities Laws by Autodesk, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Autodesk, Inc. (NASDAQ: ADSK) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. NASDAQ: ADSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investors who lost money with shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) sho …
An investor, who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS), filed a lawsuit over alleged violations of Federal Securities Laws by AST SpaceMobile, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 17, 2024. NASDAQ: ASTS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors who lost money with shares of Sharecare, Inc. (NASDA …
An investor, who purchased shares of Sharecare, Inc. (NASDAQ: SHCR), filed a lawsuit over alleged violations of Federal Securities Laws by Sharecare, Inc.
Investors who purchased shares of Sharecare, Inc. (NASDAQ: SHCR) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2024. NASDAQ: SHCR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Atlanta, GA based Sharecare, Inc. operates as…
More Releases for Athenex
Sodium Bicarbonate Injection Market Recovery and Impact Analysis Report | Amphas …
The latest market research report released by SMI, on the Global "Sodium Bicarbonate Injection Market 2022" is segmented by region (country), company, and Application. It can declare the latest updates and powerful insights on the Sodium Bicarbonate Injection industry to help you improve your business strategy and ensure strong revenue growth for years to come. The report provides a valuable resource for market participants, investors, business stakeholders, and new entrants…
Doxorubicin Injection Market 2021 Healthcare, Clinical Reviews, Survey Reports- …
The “Doxorubicin Injection Market” report is an in-depth study of the market, along with an analysis of its key segments. The relationship is built through extensive primary and secondary research. In-depth market data is generated through interviews and data collection from industry experts and professionals. The study is a detailed document on key aspects of the markets including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis.
The report is updated with…
Investigation announced for Investors in shares of Athenex, Inc. (NASDAQ: ATNX)
Certain directors of Athenex Inc. are under investigation over potential breaches of fiduciary duties.
Investors who are current long term investors in Athenex, Inc. (NASDAQ: ATNX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ATNX stocks follows a lawsuit filed against Athenex, Inc. over alleged securities laws violations.…
U.S. Compounding Pharmacies Market By Industry Players B. Braun, Fagron, Athenex …
U.S. Compounding Pharmacies Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
Large number of patients increasingly preferring prescription drugs may augment the U.S. compounding market growth. Compounded bioidentical menopausal hormone drugs are gaining grip among women in the…
Deadline on May 3rd coming up in Lawsuit for Investors in Athenex, Inc. (NASDAQ: …
A deadline is coming up on May 3, 2021 in the lawsuit filed for certain investors of Athenex, Inc. (NASDAQ: ATNX) over alleged securities laws violations by Athenex, Inc.
Investors who purchased shares of Athenex, Inc. (NASDAQ: ATNX) have certain options and there are strict and short deadlines running. Deadline: May 3, 2021. NASDAQ: ATNX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Lawsuit filed for Investors in shares of Athenex, Inc. (NASDAQ: ATNX)
An investor, who purchased shares of Athenex, Inc. (NASDAQ: ATNX), filed a lawsuit over alleged violations of Federal Securities Laws by Athenex, Inc.
Investors who purchased shares of Athenex, Inc. (NASDAQ: ATNX) have certain options and for certain investors are short and strict deadlines running. Deadline: May 3, 2021. NASDAQ: ATNX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Buffalo, NY based Athenex, Inc., a biopharmaceutical…
